Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky M Avery

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Antimicrobial Agents and Chemotherapy|December 16, 2015
Identification and Characterization of FTY720 for the Treatment of Human African TrypanosomiasisAmy J Jones, Marcel Kaiser, Vicky M Avery
Antimicrobial Agents and Chemotherapy|January 21, 2016
Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum GametocytesLeonardo Lucantoni, David A Fidock, Vicky M Avery
Drug Discovery Today|June 26, 2017
Leishmaniasis drug discovery: recent progress and challenges in assay developmentBilal Zulfiqar, Todd B Shelper, Vicky M Avery
Journal of Natural Products|March 6, 2009
Citronamides A and B, tetrapeptides from the Australian sponge Citronia astraAnthony R Carroll, Sandra Duffy, Vicky M Avery
The Journal of Organic Chemistry|November 4, 2010
Aplidiopsamine A, an antiplasmodial alkaloid from the temperate Australian ascidian, Aplidiopsis confluataAnthony R Carroll, Sandra Duffy, Vicky M Avery
BMC Cancer|January 7, 2018
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteinsCarrie J Lovitt, Todd B Shelper, Vicky M Avery
Antioxidants (Basel, Switzerland)|November 14, 2020
Hemin Prevents Increased Glycolysis in Macrophages upon Activation: Protection by Microbiota-Derived Metabolites of PolyphenolsCatalina Carrasco-Pozo, Kah Ni Tan, Vicky M Avery
Assay and Drug Development Technologies|October 14, 2014
Miniaturized three-dimensional cancer model for drug evaluationCarrie J Lovitt, Todd B Shelper, Vicky M Avery
Microorganisms|February 25, 2023
Impact of Laboratory-Adapted Intracellular <i>Trypanosoma cruzi</i> Strains on the Activity Profiles of Compounds with Anti-<i>T. cruzi</i> ActivityMelissa L Sykes, Emily K Kennedy, Vicky M Avery
Expert Opinion on Drug Discovery|July 26, 2016
Cancer drug discovery: recent innovative approaches to tumor modelingCarrie J Lovitt, Todd B Shelper, Vicky M Avery
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|December 16, 2015
Identification and Characterization of FTY720 for the Treatment of Human African TrypanosomiasisAmy J Jones, Marcel Kaiser, Vicky M Avery
Antimicrobial Agents and Chemotherapy|January 21, 2016
Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum GametocytesLeonardo Lucantoni, David A Fidock, Vicky M Avery
Drug Discovery Today|June 26, 2017
Leishmaniasis drug discovery: recent progress and challenges in assay developmentBilal Zulfiqar, Todd B Shelper, Vicky M Avery
Journal of Natural Products|March 6, 2009
Citronamides A and B, tetrapeptides from the Australian sponge Citronia astraAnthony R Carroll, Sandra Duffy, Vicky M Avery
The Journal of Organic Chemistry|November 4, 2010
Aplidiopsamine A, an antiplasmodial alkaloid from the temperate Australian ascidian, Aplidiopsis confluataAnthony R Carroll, Sandra Duffy, Vicky M Avery
BMC Cancer|January 7, 2018
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteinsCarrie J Lovitt, Todd B Shelper, Vicky M Avery
Antioxidants (Basel, Switzerland)|November 14, 2020
Hemin Prevents Increased Glycolysis in Macrophages upon Activation: Protection by Microbiota-Derived Metabolites of PolyphenolsCatalina Carrasco-Pozo, Kah Ni Tan, Vicky M Avery
Assay and Drug Development Technologies|October 14, 2014
Miniaturized three-dimensional cancer model for drug evaluationCarrie J Lovitt, Todd B Shelper, Vicky M Avery
Microorganisms|February 25, 2023
Impact of Laboratory-Adapted Intracellular <i>Trypanosoma cruzi</i> Strains on the Activity Profiles of Compounds with Anti-<i>T. cruzi</i> ActivityMelissa L Sykes, Emily K Kennedy, Vicky M Avery
Expert Opinion on Drug Discovery|July 26, 2016
Cancer drug discovery: recent innovative approaches to tumor modelingCarrie J Lovitt, Todd B Shelper, Vicky M Avery
Pageof 22